Literature DB >> 33656432

Increase in disseminated TB during the COVID-19 pandemic.

J Barrett1, H Painter1, A Rajgopal2, D Keane1, L John1, P Papineni1, A Whittington1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33656432     DOI： 10.5588/ijtld.20.0846

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  4 in total

1.  The effects of COVID-19 pandemic on patients with lower extremity peripheral arterial disease: A near miss disaster.

Authors:  Rafael Trunfio; Céline Deslarzes-Dubuis; Giacomo Buso; Marco Fresa; Juliette Brusa; Adrian Stefanescu; Matthieu Zellweger; Jean-Marc Corpataux; Sébastien Deglise; Lucia Mazzolai
Journal:  Ann Vasc Surg       Date:  2021-08-16       Impact factor: 1.466

Review 2.  The Dark Side of the COVID-19 Treatments on Mycobacterium Tuberculosis Infection.

Authors:  Flavio De Maio; Delia Mercedes Bianco; Giovanni Delogu
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-03-01       Impact factor: 2.576

3.  Ending tuberculosis: the cost of missing the World Health Organization target in a low-incidence country.

Authors:  James O'Connell; Cora McNally; Debbi Stanistreet; Eoghan de Barra; Samuel J McConkey
Journal:  Ir J Med Sci       Date:  2022-09-19       Impact factor: 2.089

4.  Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital.

Authors:  Francesco Di Gennaro; Gina Gualano; Laura Timelli; Pietro Vittozzi; Virginia Di Bari; Raffaella Libertone; Carlotta Cerva; Luigi Pinnarelli; Carla Nisii; Stefania Ianniello; Silvia Mosti; Nazario Bevilacqua; Fabio Iacomi; Annalisa Mondi; Simone Topino; Delia Goletti; Francesco Vaia; Giuseppe Ippolito; Enrico Girardi; Fabrizio Palmieri
Journal:  Antibiotics (Basel)       Date:  2021-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.